| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4271256 | The Journal of Sexual Medicine | 2011 | 9 Pages |
Abstract
Gepirone-ER may have efficacy in the treatment of HSDD among depressed and possibly nondepressed women. Efficacy occurs by week 2, and does not seem to be purely an antidepressant effect. Fabre LF, Brown CS, Smith LC, and DeRogatis LR. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Louis F. MD, PhD, Candace S. PharmD, Louis C. PhD, Leonard R. PhD,